Navigation Links
Global Computational Biology Market Report 2013 - 2018
Date:1/9/2014

DUBLIN, January 9, 2014 /PRNewswire/ --


Research and Markets (http://www.researchandmarkets.com/research/x7rj4s/computational) has announced the addition of the "Global Computational Biology Market Report 2013 - 2018" report to their offering.
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The computational biology market deals with the use of biology and computers for drug discovery and drug development. This is conducted through modeling and simulation models for pharmacokinetics and pharmacodynamics. Rise in late stage drug failure coupled with contraction of innovative drugs has led to huge financial losses to the biotech pharmaceutical companies. It has therefore become imperative for pharmaceutical companies to invest in computational biology. In 2011, the global computational biology market was valued to be USD 760.2 million and is expected to grow at a CAGR of 21.3% from 2012 to 2018.

Computational biology also helps to reduce extensive use of humans in trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research. The drug discovery market accounts to be the largest market for computational biology as its use at this stage helps in reduction of drug failure in the subsequent phase i.e. development phase. Currently, there is a large market of contract service providers of computational biology; nonetheless multinational pharmaceutical companies are setting up their own computational biology centers to fasten the process of drug discovery and development. Governments across the globe are funding infrastructure and academic courses to improve and increase the number of computational biologists.

Large pharmaceutical companies such as Pfizer, Roche, Novartis, and Sanofi are now exploring this market to have better outcomes of clinical trials. The drugs which have failed in the last stage of clinical trials are also being studied using computational biology to understand and apply its use for other disease indications. Though North America remains the largest market in the world, Asian countries namely India and China are witnessing fast growth and are predicted to emerge as dominating markets in the near future. The major players of this market are Schrödinger, Accelrys, Compugen, Entelos, Rhenovia Pharma and others.


Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Computational Biology Market Dynamics

Chapter 4 Global Computational Biology Market, by Applications

Chapter 5 Global Computational Biology Market, by Tools

Chapter 6 Global Computational Biology Market, by Services

Chapter 7 Global Computational Biology Market, by Geography

Chapter 8 Market Share Analysis

Chapter 9 Recommendations

Chapter 10 Company Profiles


Companies Mentioned:

  • Accelrys
  • Certara
  • Chemical Computing Group Inc.
  • Compugen, Ltd
  • Entelos
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc
  • Nimbus Discovery LLC
  • Rhenovia Pharma SAS
  • Schrodinger
  • Simulation Plus, Inc


For more information visit http://www.researchandmarkets.com/research/x7rj4s/computational


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PRA Nominated for "Best CRO" Award in Global Contest for Second Year
2. CSSi, the Leader in Global Patient Recruitment Solutions for Clinical Trials Industry, Rolls Out Redesigned Website: www.CSSiEnroll.com
3. Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
4. Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
5. Growth in Bioscience and Pharmaceutical R&D Drives the Market for Gene Expression Reagents, According to a New Trend Report Published by Global Industry Analysts, Inc.
6. EY Global Life Sciences Center Announces New Appointments to Its Leadership Team
7. Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research
8. Growing Focus on Reducing Drug Development Costs to Drive the Market for Biosimulation, According to a New Trend Report Published by Global Industry Analysts, Inc.
9. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
10. Paraformaldehyde Industry 2014 Global & China Development Analysis in a New Research Study Available at DeepResearchReports.com
11. Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Antonio, TX (PRWEB) , ... February 23, 2017 ... ... Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the ... indicated for adults at home or in healthcare facilities during periods of rest. ...
(Date:2/23/2017)... ... 23, 2017 , ... The Greater Gift Initiative, Inc , (GGI) a ... Research . GGI's mission is to advance global health and highlight the greater good ... honor of each clinical trial volunteer. The vision of GGI is to serve as ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one ... been named Fellows of the Society this year, the Fellows Committee has announced. ... fields of optics, photonics, and imaging as well as their service to the ...
(Date:2/22/2017)... 2017  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Annual Biocom Global Life Science Partnering Conference.  The presentation ... at the Torrey Pines Lodge, in San Diego.  ... Biocom who have chosen our company, amongst numerous others, ... investors, and clinical researchers," said Mr. Chen. "In contrast ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/25/2017)... 2017 The Elements of Enterprise Information Security ... comprised of a comprehensive set of business processes ... digital identities and providing a secured and documented ... significant number of programs opted by enterprises to ... optimizing processes and changing policies. However, there are ...
Breaking Biology News(10 mins):